Cynosure, Inc. (Cynosure) develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive procedures to remove hair, treat vascular lesions, rejuvenate skin through the treatment of shallow vascular lesions and pigmented lesions, as well as multi-colored tattoos, temporarily reduce the appearance of cellulite, treat wrinkles, skin texture, skin discoloration and skin tightening, and to perform minimally invasive procedures for LaserBodySculpting for the removal of unwanted fat. Its systems incorporate a range of laser and other light-based energy sources, including Alexandrite, pulse dye, Nd:Yag and diode lasers, as well as intense pulsed light. Cynosure sells 18 different aesthetic treatment systems. Its flagship products are the Apogee Elite system; the Cynergy system; the TriActive LaserDermology system; the Affirm and Affirm carbon dioxide (CO2) systems, Smartlipo and Smartlipo MPX systems, and the Accolade system.